Cytek Biosciences partners with Bio-Rad to expand reagent portfolios

Cytek Biosciences (CTKB) announced that it has entered into a strategic partnership with leading life science research and clinical diagnostics products company Bio-Rad Laboratories (BIO). Under the terms of the agreement, Bio-Rad’s exceptionally bright, high-performing new StarBright Dyes will be available to Cytek to develop and commercialize reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems. Bio-Rad’s StarBright Dyes have been designed to be stable with superior brightness, narrow excitation and emission characteristics for minimized spillover and improved resolution of specific cell populations, allowing researchers to build bigger, better panels. "Our focus has always been to provide a complete cell analysis solution to our customers, and the addition of Bio-Rad StarBright Dyes to our FSP platform is a big win for researchers conducting multiparameter experiments," noted Wenbin Jiang, CEO of Cytek Biosciences. "Researchers will be able to expand multiparameter analysis into violet and UV channels with Cytek-optimized reagents, unleashing the full power of FSP technology to obtain better resolution and a deeper understanding of populations."